Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Frank Griscelli and Laurence Albiges.
Frank Griscelli
Connection Strength
0.587
Laurence Albiges
  1. Severe COVID-19 in patients with hematological cancers presenting with viremia. Ann Oncol. 2021 10; 32(10):1297-1300.
    View in: PubMed
    Score: 0.239
  2. Bamlanivimab + etesevimab therapy induces SARS-CoV-2 immune escape mutations and secondary clinical deterioration in COVID-19 patients with B-cell malignancies. Ann Oncol. 2021 11; 32(11):1445-1447.
    View in: PubMed
    Score: 0.060
  3. Prolonged SARS-CoV-2 RNA virus shedding and lymphopenia are hallmarks of COVID-19 in cancer patients with poor prognosis. Cell Death Differ. 2021 12; 28(12):3297-3315.
    View in: PubMed
    Score: 0.060
  4. Metabolomic analyses of COVID-19 patients unravel stage-dependent and prognostic biomarkers. Cell Death Dis. 2021 03 11; 12(3):258.
    View in: PubMed
    Score: 0.058
  5. Systematic Screening of COVID-19 Disease Based on Chest CT and RT-PCR for Cancer Patients Undergoing Radiation Therapy in a Coronavirus French Hotspot. Int J Radiat Oncol Biol Phys. 2021 07 15; 110(4):947-956.
    View in: PubMed
    Score: 0.058
  6. Secondary haemophagocytic lymphohistiocytosis is a rare occurrence amongst cancer patients with COVID-19. Br J Haematol. 2021 02; 192(3):e87-e90.
    View in: PubMed
    Score: 0.057
  7. Tocilizumab, an anti-IL-6 receptor antibody, to treat COVID-19-related respiratory failure: a case report. Ann Oncol. 2020 07; 31(7):961-964.
    View in: PubMed
    Score: 0.055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.